BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11734920)

  • 21. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.
    Yazaki Y; Isobe M; Takahashi W; Kitabayashi H; Nishiyama O; Sekiguchi M; Takemura T
    Heart; 1999 Feb; 81(2):153-9. PubMed ID: 9922350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [123I-beta-methyl-iodophenyl-pentadecanoic acid myocardial scintigraphy in diabetic patients without overt ischemic heart disease].
    Shinmura K; Tani M; Suganuma Y; Hasegawa H; Kawamura M; Nakamura Y; Hashimoto J; Kubo A
    J Cardiol; 1995 Jul; 26(1):23-32. PubMed ID: 7666341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
    Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
    Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Nakata S; Shigematsu Y
    Circ J; 2002 Dec; 66(12):1139-43. PubMed ID: 12499621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction.
    Hambye AS; Dobbeleir AA; Vervaet AM; Van den Heuvel PA; Franken PR
    J Nucl Med; 1999 Sep; 40(9):1468-76. PubMed ID: 10492367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic significance of 123I-metaiodobenzylguanidine scintigraphy in dilated cardiomyopathy].
    Suzuki Y; Toyama T; Kanda T; Tsukagoshi J; Isobe N; Nagaoka H; Kubota S; Iizuka T; Imai S; Nagai R
    Kaku Igaku; 1995 Nov; 32(11):1207-15. PubMed ID: 8558789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.
    Suwa M; Ito T; Kobashi A; Yagi H; Terasaki F; Hirota Y; Kawamura K
    Am Heart J; 2000 May; 139(5):905-12. PubMed ID: 10783226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol.
    Eichhorn EJ; Heesch CM; Risser RC; Marcoux L; Hatfield B
    J Am Coll Cardiol; 1995 Jan; 25(1):154-62. PubMed ID: 7798494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of (123)I-BMIPP with myocardial imaging for evaluation of the efficacy of drug therapy in patients with chronic heart failure.
    Watanabe K; Sekiya M; Tsuruoka T; Funada JI; Miyagawa M
    J Card Fail; 2001 Sep; 7(3):257-64. PubMed ID: 11561227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol?: a case report].
    Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Nakamura T; Azuma A; Sugihara H
    J Cardiol; 2000 Sep; 36(3):183-9. PubMed ID: 11022654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serial assessment of MIBG scintigraphy in a case of DCM with heart failure improved by beta-blocker therapy].
    Yamamoto K; Asada S; Yabunouchi T; Morozumi R; Kusuoka H; Nishimura T
    Kaku Igaku; 1995 Apr; 32(4):413-8. PubMed ID: 7776548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
    Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
    J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
    Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
    J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [123I-BMIPP whole-body scintigraphy in relation to left ventricular ejection fraction].
    Matsunari I; Ichiyanagi K; Taki J; Nakajima K; Tonami N; Hisada K
    Kaku Igaku; 1994 May; 31(5):497-500. PubMed ID: 8028221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of 123I-MIBG scintigraphy for prediction of effect of beta-blocker therapy in dilated cardiomyopathy].
    Tawarahara K; Sugiyama T; Nakano T; Matou F; Kurata C; Wakabayashi Y; Shouda S; Mikami T
    Kaku Igaku; 1998 Jul; 35(6):413-20. PubMed ID: 9753920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
    Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
    J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery of iodine-123 metaiodobenzylguanidine uptake associated with left ventricular functional recovery in a patient with dilated cardiomyopathy. Endomyocardial histological findings before and after the improvement of uptake.
    Ueda T; Kusachi S; Yamaji H; Morishita N; Mima T; Imai M
    Jpn Heart J; 1997 Jan; 38(1):145-50. PubMed ID: 9186291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP.
    Taki J; Nakajima K; Matsunari I; Bunko H; Takata S; Kawasuji M; Tonami N
    J Nucl Med; 1997 Oct; 38(10):1503-10. PubMed ID: 9379183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.